Application of bacteriophage-containing aerosol against nosocomial transmission of carbapenem-resistant acinetobacter baumannii in an intensive care unit

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Ho, Yu Huai ^a   Tseng, Chun Chieh ^b   Wang, Lih Shinn ^a   Chen, Yi Ting ^a   Ho, Guan Jin ^a   Lin, Teng Yi ^a   Wang, Ling Yi ^a   Chen, Li Kuang ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBAPENEM; COLISTIMETHATE; DISINFECTANT AGENT; IMIPENEM; MEROPENEM; TIGECYCLINE; AEROSOL; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; AEROSOL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL TRANSMISSION; BACTERIOPHAGE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII INFECTION; CLEANING; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISINFECTION; DRUG USE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; INTENSIVE CARE UNIT; INTERVENTION STUDY; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT ISOLATION; PROSPECTIVE STUDY; PUBLIC HOSPITAL; TEACHING HOSPITAL; ACINETOBACTER INFECTIONS; CROSS INFECTION; DRUG EFFECTS; INFECTION CONTROL; ISOLATION AND PURIFICATION; MULTIDRUG RESISTANCE; PHYSIOLOGY; PROCEDURES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AEROSOLS; BACTERIOPHAGES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE UNITS; PROSPECTIVE STUDIES;

EID: 85006700632     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0168380     Document Type: Article

References (34)

1. Taiwan, Center for Disease Control. Statistics of communicable diseases and surveillance report in Taiwan 2003 (in English). Available: http://www.cdc.gov.tw/public/data/81910502871.pdf. 2004.
2. Taiwan, Center for Disease Control. Statistics of communicable diseases and surveillance report in Taiwan 2012 (in English). Available: http://www.cdc.gov.tw/uploads/files/201210/291a1d4a-e194-462db08d-66ba17329d46.pdf 2013.
3. Blot S, Vandewoude K, De Bacquer D, Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clinical infectious diseases. 2002; 34(12):1600-6. doi: 10.1086/340616 PMID: 12032895
4. Wilson SJ, Knipe CJ, Zieger MJ, Gabehart KM, Goodman JE, Volk HM, et al. Direct costs of multidrugresistant Acinetobacter baumannii in the burn unit of a public teaching hospital. American journal of infection control. 2004; 32(6):342-4. doi: 10.1016/j.ajic.2004.02.008 PMID: 15454892
5. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infection Control & Hospital Epidemiology. 2007; 28(06):713-9.
6. Tseng YC, Wang JT, Wu FLL, Chen YC, Chie WC, Chang SC. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagnostic microbiology and infectious disease. 2007; 59(2):181-90. doi: 10.1016/j.diagmicrobio.2007.04.024 PMID: 17662564
7. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. The Lancet infectious diseases. 2008; 8(12):751-62. doi: 10.1016/S1473-3099 (08)70279-2 PMID: 19022191
8. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Committee HICPA. Management of multidrug-resistant organisms in health care settings, 2006. American journal of infection control. 2007; 35(10):S165-S93.
9. Manian FA, Griesnauer S, Senkel D. Impact of terminal cleaning and disinfection on isolation of Acinetobacter baumannii complex from inanimate surfaces of hospital rooms by quantitative and qualitative methods. American journal of infection control. 2013; 41(4):384-5. doi: 10.1016/j.ajic.2012.04.321 PMID: 23040606
10. Manian FA, Griesenauer S, Senkel D, Setzer JM, Doll SA, Perry AM, et al. Isolation of Acinetobacter baumannii complex and methicillin-resistant Staphylococcus aureus from hospital rooms following terminal cleaning and disinfection: can we do better? Infection Control & Hospital Epidemiology. 2011; 32 (07):667-72.
11. Jeon J, D'Souza R, Pinto N, Ryu CM, Park J, Yong D, et al. Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates. Journal of applied microbiology. 2016. Epub 2016/03/19.
12. Peng F, Mi Z, Huang Y, Yuan X, Niu W, Wang Y, et al. Characterization, sequencing and comparative genomic analysis of vB-AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. BMC microbiology. 2014; 14:181. Epub 2014/07/06. PubMed Central PMCID: PMCPmc4094691. doi: 10.1186/1471-2180-14-181 PMID: 24996449
13. Shen GH, Wang JL, Wen FS, Chang KM, Kuo CF, Lin CH, et al. Isolation and characterization of phikm18p, a novel lytic phage with therapeutic potential against extensively drug resistant Acinetobacter baumannii. PloS one. 2012; 7(10):e46537. Epub 2012/10/17. PubMed Central PMCID: PMCPmc3465330. doi: 10.1371/journal.pone.0046537 PMID: 23071586
14. Lai MJ, Soo PC, Lin NT, Hu A, Chen YJ, Chen LK, et al. Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. International journal of antimicrobial agents. 2013; 42(2):141-8. Epub 2013/06/08. doi: 10.1016/j.ijantimicag.2013.04.022 PMID: 23742833
15. Lai MJ, Lin NT, Hu A, Soo PC, Chen LK, Chen LH, et al. Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both gram-positive and gram-negative bacteria. Applied microbiology and biotechnology. 2011; 90(2):529-39. Epub 2011/01/26. doi: 10.1007/s00253-011-3104-y PMID: 21264466
16. Chang KC, Lin NT, Hu A, Lin YS, Chen LK, Lai MJ. Genomic analysis of bacteriophage varphiAB1, a varphiKMV-like virus infecting multidrug-resistant Acinetobacter baumannii. Genomics. 2011; 97 (4):249-55. Epub 2011/01/19. doi: 10.1016/j.ygeno.2011.01.002 PMID: 21241792
17. Lin NT, Chiou PY, Chang KC, Chen LK, Lai MJ. Isolation and characterization of ?AB2: a novel bacteriophage of Acinetobacter baumannii. Research in microbiology. 2010; 161(4):308-14. doi: 10.1016/j. resmic.2010.03.007 PMID: 20385229
18. Merabishvili M, Pirnay JP, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, et al. Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials. PloS one. 2009; 4(3):e4944. doi: 10.1371/journal.pone.0004944 PMID: 19300511
19. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. Journal of clinical microbiology. 1998; 36 (7):1938-41. Epub 1998/07/03. PubMed Central PMCID: PMCPmc104956. PMID: 9650940
20. Tacconelli E, Cataldo M, Dancer S, Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clinical Microbiology and Infection. 2014; 20(s1):1-55.
21. Villegas MV, Hartstein AI. Acinetobacter Outbreaks, 1977-2000. Infection Control & Hospital Epidemiology. 2003; 24(04):284-95.
22. Sulakvelidze A, Alavidze Z, Morris JG. Bacteriophage therapy. Antimicrobial agents and chemotherapy. 2001; 45(3):649-59. doi: 10.1128/AAC.45.3.649-659.2001 PMID: 11181338
23. Burrowes B, Harper DR, Anderson J, McConville M, Enright MC. Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert review of anti-infective therapy. 2011; 9(9):775-85. doi: 10.1586/eri.11.90 PMID: 21905786
24. Eaton MD, Bayne-Jones S. Bacteriophage therapy: review of the principles and results of the use of bacteriophage in the treatment of infections. Journal of the American Medical Association. 1934; 103 (24):1847-53.
25. Sabour PM, Griffiths MW. Bacteriophages in the control of food-and waterborne pathogens: American Society for Microbiology Press; 2010.
26. Abuladze T, Li M, Menetrez MY, Dean T, Senecal A, Sulakvelidze A. Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157: H7. Applied and environmental microbiology. 2008; 74(20):6230-8. doi: 10.1128/AEM.01465-08 PMID: 18723643
27. Leverentz B, Conway WS, Camp MJ, Janisiewicz WJ, Abuladze T, Yang M, et al. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Applied and environmental microbiology. 2003; 69(8):4519-26. doi: 10.1128/AEM.69.8.4519-4526.2003 PMID: 12902237
28. Thiel K. Old dogma, new tricks-21st Century phage therapy. Nature biotechnology. 2004; 22(1):31-6. doi: 10.1038/nbt0104-31 PMID: 14704699
29. Chen LK, Liu YL, Hu A, Chang KC, Lin NT, Lai MJ, et al. Potential of bacteriophage ΦAB2 as an environmental biocontrol agent for the control of multidrug-resistant Acinetobacter baumannii. BMC microbiology. 2013; 13(1):1.
30. Karageorgopoulos DE, Falagas ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. The Lancet Infectious diseases. 2008; 8(12):751-62. Epub 2008/11/22. doi: 10. 1016/S1473-3099(08)70279-2 PMID: 19022191
31. Cho OH, Bak MH, Baek EH, Park KH, Kim S, Bae IG. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective. Am J Infect Control. 2014; 42(9):976-9. Epub 2014/09/03. doi: 10.1016/j.ajic.2014.05.027 PMID: 25179329
32. Ho YH, Wang LS, Jiang HL, Chang CH, Hsieh CJ, Chang DC, et al. Use of a Sampling Area-Adjusted Adenosine Triphosphate Bioluminescence Assay Based on Digital Image Quantification to Assess the Cleanliness of Hospital Surfaces. International journal of environmental research and public health. 2016; 13(6). Epub 2016/06/15.
33. Sherlock O, O'Connell N, Creamer E, Humphreys H. Is it really clean? An evaluation of the efficacy of four methods for determining hospital cleanliness. The Journal of hospital infection. 2009; 72(2):140-6. Epub 2009/03/27. doi: 10.1016/j.jhin.2009.02.013 PMID: 19321226
34. Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D. Experimental phage therapy against Staphylococcus aureus in mice. Antimicrobial agents and chemotherapy. 2007; 51(8):2765-73. doi: 10.1128/ AAC.01513-06 PMID: 17517843